Bank of New York Mellon’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,383
| Closed | -$201K | – | 4582 |
|
|
2022
Q1 | $201K | Sell |
4,383
-2,762
| -39% | -$127K | ﹤0.01% | 4234 |
|
|
2021
Q4 | $438K | Sell |
7,145
-4,914
| -41% | -$301K | ﹤0.01% | 3884 |
|
|
2021
Q3 | $901K | Sell |
12,059
-235
| -2% | -$17.6K | ﹤0.01% | 3445 |
|
|
2021
Q2 | $1.14M | Buy |
12,294
+5,417
| +79% | +$501K | ﹤0.01% | 3321 |
|
|
2021
Q1 | $610K | Buy |
6,877
+3,305
| +93% | +$293K | ﹤0.01% | 3575 |
|
|
2020
Q4 | $333K | Buy |
+3,572
| New | +$333K | ﹤0.01% | 3786 |
|
|
2020
Q2 | – | Sell |
-6,875
| Closed | -$215K | – | 4084 |
|
|
2020
Q1 | $215K | Buy |
+6,875
| New | +$215K | ﹤0.01% | 3720 |
|
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$295K | – | 4176 |
|
|
2019
Q3 | $295K | Buy |
+10,000
| New | +$295K | ﹤0.01% | 3776 |
|